Significant time has passed since the coronavirus disease of 2019 (COVID-19) pandemic
outbreak, which led to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

Currently, few evidences have shown the possible involvement of autoimmunity in patients
affected by coronavirus disease 2019 (COVID‐19). In this study, we elucidate whether …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can give rise to
different clinical manifestations that are directly related to viral tissue damage or indirectly …

Increasing evidence accumulated from the past year on the outbreak of corona virus disease
2019 (COVID-19) pandemic, suggesting a strong association between the severe acute …

Patients sero-positive for the Systemic Acute Respiratory Syndrome Corona virus2 (SARS-
CoV2) virus develop the Corona Virus Disease 2019 (CoViD-19). CoViD-19 may be …

Background Identifying individuals with a higher risk of developing severe coronavirus
disease 2019 (COVID-19) outcomes will inform targeted and more intensive clinical …

After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-
2-associated disease at the end of December 2019, the virus spread quickly throughout the …

The clinical and immunological spectrum of acute and post-active COVID-19 syndrome
overlaps with criteria used to characterize autoimmune diseases such as rheumatoid …

Recently, Chen Tao (Doctor) and colleagues published a retrospective study, and
delineated the clinical characteristics of patients with coronavirus disease 2019 (COVID-19) …

Acute COVID-19, caused by SARS-CoV-2, is characterized by diverse clinical presentations,
ranging from asymptomatic infection to fatal respiratory failure, and often associated with …